MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) represents a novel class of mitochondrial-derived peptides that regulate metabolic homeostasis, nuclear gene expression, and cellular stress responses. This technical MOTS-C FAQ provides laboratory investigators with detailed analytical specs, reconstitution protocols, storage parameters, and preclinical mechanism data for in vitro and animal studies. All PX1 Research compounds are synthesized in the USA, strictly for laboratory research use only.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) represents a novel class of mitochondrial-derived peptides that regulate metabolic homeostasis, nuclear gene expression, and cellular stress responses. This technical MOTS-C FAQ provides laboratory investigators with detailed analytical specs, reconstitution protocols, storage parameters, and preclinical mechanism data for in vitro and animal studies. All PX1 Research compounds are synthesized in the USA, strictly for laboratory research use only.
Mitochondrial-derived peptides (MDPs) are short, biologically active peptides encoded within short open reading frames (sORFs) of the mitochondrial genome. While the vast majority of cellular peptides originate from nuclear DNA, MOTS-c is translated directly from the 12S ribosomal RNA gene located within the mitochondrion. Synthesized as a 16-amino acid peptide (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg), MOTS-c serves as an intercellular and intracellular signaling molecule that bridges mitochondrial metabolic status with nuclear gene expression.
In preclinical research, investigators utilize MDPs to elucidate non-canonical mitochondrial signaling pathways. Research published across molecular biology literature demonstrates that under cellular stress conditions—such as nutrient depletion or oxidative challenge—MOTS-c translocates from the mitochondrion to the cell nucleus. In the nucleus, it binds specific transcription factors to alter adaptive gene expression. Researchers interested in exploring the broader context of mitochondrial genetics can consult our comprehensive research library for updated peer-reviewed literature reviews.
Preclinical studies indicate that MOTS-c acts as a master regulator of metabolic homeostasis. In mouse models and primary cell cultures, MOTS-c administration has been observed to activate 5'-AMP-activated protein kinase (AMPK), a central cellular energy sensor. Activation of AMPK by MOTS-c leads to downstream phosphorylation events that promote glucose uptake, enhance fatty acid oxidation, and inhibit anabolic lipid synthesis.
Furthermore, rodent models evaluating physical performance suggest that MOTS-c treatment significantly enhances skeletal muscle insulin sensitivity and exercise capacity. In vitro data indicate that MOTS-c influences the folate cycle and de novo purine synthesis pathways, indirectly modifying AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) levels to drive AMPK activation. These unique physiological mechanisms position MOTS-c as a primary subject in metabolic research peptides investigations targetting metabolic syndrome, age-related metabolic decline, and physical exertion adaptation.
To properly contextualize MOTS-c within mitochondrial signaling research, laboratory investigators often contrast its functional profile with other mitochondrial-targeted compounds. While conventional peptides focus primarily on extracellular receptor binding, MDPs and mitochondria-targeted peptides interact directly with organellar membranes or nuclear transcription networks.
For example, Humanin is another prominent mitochondrial-derived peptide studied primarily for cytoprotective and anti-apoptotic properties in neuronal and vascular models. In contrast, SS-31 (Elamipretide) is a synthetic tetrapeptide engineered to selectively target cardiolipin in the inner mitochondrial membrane, optimizing electron transport chain efficiency and reducing ROS production. While SS-31 acts locally on membrane integrity and Humanin focuses on cell survival signaling, MOTS-c functions primarily as a metabolic governor operating at the systemic and nuclear transcription levels. Researchers investigating tissue regeneration alongside metabolic signaling often evaluate BPC-157 or AOD-9604 in parallel assay designs to establish comparative baseline responses.
In vitro and animal models require strict compound purity to yield reliable, reproducible experimental data. Contaminants such as residual synthesis reagents, truncated peptide fragments, or organic solvents can induce off-target cytotoxic effects or confounding inflammatory signaling in cell culture.
PX1 Research ensures that every batch of MOTS-c undergoes rigorous identity and purity testing via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) at an independent ISO 17025 accredited laboratory. Our benchmark purity standard requires ≥98% main peak area by HPLC, with MS spectral analysis confirming the precise theoretical molecular weight of 2174.6 g/mol. Every order includes a lot-specific Certificate of Analysis (COA) documenting analytical chromatography profiles.
Endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant risk in cell culture and animal model experimentation. Even minute concentrations of endotoxin can trigger Toll-like receptor 4 (TLR4) activation, inducing unwanted proinflammatory cytokine expression that invalidates metabolic and gene expression assays.
To ensure experimental validity, PX1 Research subjects all peptide lots to chromogenic Limulus Amebocyte Lysate (LAL) testing. Our research compounds are verified to contain endotoxin levels strictly under <0.01 EU/mg. This exceptional purity parameter ensures that metabolic changes observed during MOTS-c assays stem entirely from peptide-receptor interactions rather than background endotoxin exposure.
Lyophilized MOTS-c must be reconstituted under sterile conditions using appropriate laboratory solvents depending on the target experimental model. For cell culture and short-term assays, sterile Bacteriostatic Water (containing 0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4) is typically selected.
When reconstituting, allow the vial to reach room temperature before adding the solvent to prevent moisture condensation. Reconstitution volume should be calculated based on desired stock concentration (e.g., 2 mg/mL or 5 mg/mL). Direct the solvent stream gently against the glass wall of the vial rather than shooting directly onto the lyophilized cake. Gently swirl or invert the vial until completely dissolved. Never vortex peptide solutions, as mechanical shear forces can cause aggregation or denaturation of the peptide structure.
Lyophilized peptide stability depends heavily on temperature and humidity control. Prior to reconstitution, lyophilized MOTS-c should be stored at -20°C for short-to-medium term storage or at -80°C for long-term storage (exceeding 12 months) in a desiccated environment protected from light.
Once reconstituted into aqueous solution, peptide stability decreases significantly. Reconstituted stock solutions stored at 2°C to 8°C should be used within 7 to 14 days. For extended utility, stock solutions should be aliquoted into single-use microcentrifuge tubes and frozen at -80°C to minimize degradation from repeated freeze-thaw cycles. Research laboratories establishing large-scale protocol series can source bulk quantities through our dedicated wholesale portal to maintain consistent lot utilization across long-term studies.
Reliable research outcomes require dependable supplier standards. PX1 Research synthesizes all research peptides in USA-based, GMP-compliant facilities utilizing state-of-the-art solid-phase peptide synthesis (SPPS) methodologies. Each lot undergoes comprehensive third-party testing before release.
To support tight laboratory timelines, PX1 Research maintains distribution facilities in both California and Arizona. Orders placed Monday through Friday ship same-day, ensuring fast transit across North America. Laboratories can browse our catalog of research peptides with complete confidence in product verification, supply chain integrity, and clear analytical documentation.
What is MOTS-c and how is it synthesized for laboratory research?
MOTS-c is a 16-amino acid peptide derived from the mitochondrial 12S rRNA gene. For laboratory research use, it is produced via automated solid-phase peptide synthesis (SPPS), purified by reverse-phase HPLC, and lyophilized into a stable powder.
What primary mechanisms are studied with MOTS-c in preclinical research?
Preclinical studies investigate MOTS-c for its role in AMPK activation, nuclear gene expression modulation under metabolic stress, skeletal muscle glucose uptake, and exercise-capacity regulation in animal models.
How does MOTS-c differ from standard nuclear-encoded peptides?
Unlike peptides encoded in the cell nucleus, MOTS-c is encoded within the mitochondrial genome. It functions as a retrograde signal, translocating to the cell nucleus during metabolic stress to directly regulate nuclear gene transcription.
What analytical methods verify the quality of PX1 Research MOTS-c?
Every lot of PX1 Research MOTS-c undergoes High-Performance Liquid Chromatography (HPLC) to verify ≥98% purity and Mass Spectrometry (MS) to confirm exact molecular weight, documented in a lot-specific COA.
What endotoxin standard applies to PX1 Research MOTS-c?
PX1 Research peptides are LAL-tested to ensure endotoxin levels remain below <0.01 EU/mg, protecting in vitro cell cultures and animal models from confounding inflammatory artifacts.
How should lyophilized MOTS-c be stored upon delivery?
Lyophilized MOTS-c should be stored at -20°C for short-term use or -80°C for long-term storage in a dry, dark environment to maintain chemical stability.
What solvent is recommended for reconstituting MOTS-c for laboratory assays?
Sterile Bacteriostatic Water or sterile PBS (pH 7.4) is typically used to reconstitute MOTS-c depending on whether the experimental protocol involves long-term multi-use stock storage or immediate cell culture treatment.
How should reconstituted MOTS-c stock solutions be handled to avoid degradation?
Reconstituted solutions should be stored at 2–8°C for up to 14 days or divided into single-use aliquots and frozen at -80°C. Repeated freeze-thaw cycles and vortexing must be avoided.
How does MOTS-c compare to SS-31 and Humanin in mitochondrial studies?
Humanin is primarily studied for cytoprotection and anti-apoptotic effects; SS-31 targets inner mitochondrial cardiolipin to reduce ROS; MOTS-c specifically regulates systemic metabolic homeostasis, glucose handling, and nuclear transcription.
Can academic and institutional labs purchase MOTS-c in bulk from PX1 Research?
Yes, high-volume and institutional laboratories can order bulk quantities and set up recurring account procurement through the PX1 Research wholesale portal.
Where does PX1 Research ship MOTS-c from, and what are the dispatch timelines?
PX1 Research dispatches all peptide orders same-day Monday through Friday from our centralized shipping centers located in California and Arizona.
Is MOTS-c approved for human consumption or therapeutic administration?
No. MOTS-c supplied by PX1 Research is strictly designated for laboratory research use only in vitro or in preclinical animal models. Human or therapeutic use is strictly prohibited.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.